Literature DB >> 25242096

Association of clinicopathological characteristics with secondary neoplastic lymphoproliferative disorders in patients with lymphomatoid papulosis.

Vassiliki Nikolaou1, Evangelia Papadavid, Afroditi Ekonomidi, Maria Dalamaga, Leonidas Marinos, Alexandros Stratigos, Theodora Papadaki, Christina Antoniou.   

Abstract

Lymphomatoid papulosis (LyP) refers to an indolent cutaneous lymphoma. The association of prognostic clinicopathological risk factors with a second hematologic malignancy has not yet been determined. We investigated the prognostic effect of clinicopathological characteristics on the occurrence of a second lymphoma, as well as the first-line treatment, in 24 patients diagnosed with LyP using logistic regression models. We showed that lymphoma occurrence was associated with a lower mean age at onset of LyP symptoms, histological types B and C, head-located LyP lesions and a higher frequency of LyP recurrences. In multivariate analyses, histologic type A was associated with a lower risk of second lymphoma (odds ratio [OR] = 0.12, 95% confidence interval [CI] 0.014-0.98; p = 0.045) adjusting for age of LyP first symptomatology, and an important increased lymphoma-free survival rate (long-rank test; p = 0.06). Clinicopathological characteristics are important in defining the clearance or persistence of LyP lesions and may predict the occurrence of a second lymphoma.

Entities:  

Keywords:  Lymphoma and Hodgkin disease; chemotherapeutic approaches; prognostication

Mesh:

Year:  2014        PMID: 25242096     DOI: 10.3109/10428194.2014.958821

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  1 in total

1.  Evaluation of Associated Lymphomas and Their Risk Factors in Patients with Lymphomatoid Papulosis: A Retrospective Single-Center Study from Turkey

Authors:  Can Baykal; Sıla Kılıç Sayar; Kurtuluş Didem Yazganoğlu; Nesimi Büyükbabani
Journal:  Turk J Haematol       Date:  2021-01-04       Impact factor: 1.831

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.